Live site data
Amryt Pharma - Hope for those with the greatest need
We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare diseases.
Last refresh
Updated 22d ago
Analyst read
In review
52/100 trustStale snapshot
Detected stack
WordPressjQuery
Quick read
How to read amrytpharma.com quickly
amrytpharma.com looks like an uncategorized property. Traffic estimates are limited, so use the trust and structure modules first. Current AI trust scoring is 52/100.
What to do next
- The stack appears to include WordPress, jQuery.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
25/74 fields populated (34%)
3 health alerts13 providers
Providers with missing fields
ads: 3/5publisher: 4/5files: 2/3authority: 0/5history: 0/7traffic: 0/16whois: 0/6radar: 0/4ai: 0/7
Provider health alerts
authority: AHREFS_DR_FETCH_FAILEDhistory: ARCHIVE_HISTORY_RATE_LIMITEDtraffic: TRAFFIC_NO_DATA
View field-level status
AI analysis not available
Business intelligence will appear here once the AI analysis completes.
Keep exploring
Keep exploring from this report
Browse the related category, topic, or technology path, open alternatives, or move into comparison when you have a second domain.
Related technology
Browse Wordpress websites
Pivot from one domain into a stack-based discovery path.
Technology pages help you compare implementation patterns across similar sites.
Related technology
Browse Jquery websites
Pivot from one domain into a stack-based discovery path.
Technology pages help you compare implementation patterns across similar sites.
Alternatives
Open amrytpharma.com alternatives
Review similar domains ranked by category, audience, technology overlap, and match reasons.
Use alternatives when this report is the start of a shortlist.
Comparison
Compare similar domains
Choose an alternative and move into a side-by-side comparison from the alternatives path.